As of January 22, 2025, IO Biotech (IOBT) has a market cap of $59.299 million USD. According to our data, IO Biotech is ranked No.8058 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $59.30 M |
-2.16%
|
Dec 31, 2024 | $60.61 M |
-51.06%
|
Dec 29, 2023 | $0.12 B |
-18.26%
|
Dec 30, 2022 | $0.15 B |
-64.06%
|
Dec 31, 2021 | $0.42 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
Inovio Pharmaceuticals
INO
|
$81.23 M |
0.000 M
|
USA
|
Curevac
CVAC
|
$0.89 B |
0.000 M
|
Germany
|
Gritstone bio
GRTS
|
$3.80 M |
2.350 M
|
USA
|
Arcturus Therapeutics
ARCT
|
$0.45 B |
0.000 M
|
USA
|
Vaxart
VXRT
|
$0.19 B |
-0.000 M
|
USA
|
Dynavax Technologies
DVAX
|
$1.63 B |
-0.000 M
|
USA
|
Telesis Bio
TBIO
|
$0.53 M |
0.000 M
|
USA
|
Altimmune
ALT
|
$0.49 B |
0.000 M
|
USA
|
Agenus
AGEN
|
$86.42 M |
0.000 M
|
USA
|
Adaptimmune Therapeutics
ADAP
|
$0.15 B |
0.000 M
|
UK
|
Iovance Biotherapeutics
IOVA
|
$1.83 B |
-0.000 M
|
USA
|
Market Cap | = | IOBT Stock Price | * | IOBT Shares Outstanding |
= | $0.90 | * | 65.88 M | |
= | $59.30 M |